Results 161 to 170 of about 48,845 (222)

XY0206 targets FLT3-dependent resistance states in acute myeloid leukemia. [PDF]

open access: yesJ Clin Invest
Shen L   +20 more
europepmc   +1 more source

Correction: Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib. [PDF]

open access: yesCancer Chemother Pharmacol
Sałek-Zań A   +7 more
europepmc   +1 more source

Tyrosine kinase inhibitors in metastatic pheochromocytomas and paragangliomas: an updated systematic review and meta-analysis. [PDF]

open access: yesEndocr Relat Cancer
Xu X   +11 more
europepmc   +1 more source

Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). [PDF]

open access: yesMol Med Rep
Cui H   +10 more
europepmc   +1 more source

Identification of key symptoms impacting HRQOL in advanced renal cell carcinoma: nivolumab plus cabozantinib versus sunitinib in CheckMate 9ER. [PDF]

open access: yesOncologist
Bergerot C   +9 more
europepmc   +1 more source

YAP delactylation enhances therapy resistance in renal cell carcinoma. [PDF]

open access: yesCell Death Dis
Lin M   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy